NCT02449070View on ClinicalTrials.gov

Effects of Nicorandil on Cardiac Infarct Size in Patients With ST-segment Elevation Acute Myocardial Infarction

PHASE3UnknownINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Myocardial Infarction
Interventions
DRUG

Nicorandil

4 mg iv after randomization, 2 mg ic just before ballooning, 2 mg ic just before stenting

Trial Locations (1)

Unknown

RECRUITING

Pusan National University Hospital, Pusan

Sponsors

Collaborators (1)

JW Pharmaceutical
All Listed Sponsors
collaborator

JW Pharmaceutical

INDUSTRY

lead

Pusan National University Hospital

OTHER